Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI

Tools to properly select candidates for prostate biopsy after magnetic resonance imaging (MRI) have usually been analyzed in overall populations with suspected prostate cancer (PCa). However, the performance of these tools can change regarding the Prostate Imaging-Reporting and Data System (PI-RADS)...

Full description

Bibliographic Details
Main Authors: Miriam Campistol, Juan Morote, Marina Triquell, Lucas Regis, Ana Celma, Inés de Torres, María E. Semidey, Richard Mast, Anna Santamaría, Jacques Planas, Enrique Trilla
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cancers
Subjects:
clinically significant prostate cancer
PSA density
Proclarix
MRI-ERSPC
magnetic resonance imaging
Online Access:https://www.mdpi.com/2072-6694/14/11/2702

Internet

https://www.mdpi.com/2072-6694/14/11/2702

Similar Items